Quantum computers are starting to do real drug discovery work, not just promise it

[Jan79]

For years quantum drug discovery was almost entirely theoretical. That started changing in 2025 when St. Jude and the University of Toronto published the first study where quantum computing was used in a drug discovery pipeline with actual lab results to validate it, including for targets previously considered too difficult to design drugs for. More recently, IQM demonstrated chemically accurate molecular simulations on a 24-qubit machine using a real antiviral drug, Amantadine, as the test case. Equal1 and Kvantify announced a partnership specifically focused on quantum-enhanced drug discovery in life sciences. These are early steps and full commercial deployment is still years away, but the gap between promise and evidence is narrowing in a way that was not true even two years ago

[Cole_25]

Undruggable targets becoming druggable is one of the most genuinely exciting things I have read in this space. There are whole disease categories we have basically abandoned

[NightOwl]

A 24-qubit machine doing chemically accurate simulation of a real drug is a much more meaningful headline than any benchmark result involving fictional numbers

[IronWolf]

Early steps is doing a lot of lifting in that last paragraph. Let us see ten more studies before we start counting the lives saved

[IronFist21]

The commercial partnership angle is interesting. When companies start putting money into specific drug targets rather than general quantum hype, the incentives change

[DiamondDallas]

People keep forgetting that the bottleneck in drug discovery isn't just finding binding affinities, it is all the messy in vitro testing that follows. Even if a quantum algorithm spots the "perfect" inhibitor molecule in seconds, you still have to get it through synthesis and toxicology without it melting a liver. Exciting milestone for sure, but let's not pretend clinical trials give any discounts for quantum speedups.

[Always_David72]

Lol remember when everyone thought we would simulate every protein in a weekend by 2020? Glad to see actual chemistry happening now instead of just slide decks for venture capitalists. The transition from general hype to targeted funding is the only metric that matters at this point, and seeing real pharma cash flow into these joint ventures means the math must finally be checking out.

[QQQ]

Things are moving forward

[JonMoxley]

One thing that gets overlooked in these discussions is how difficult molecular interactions are to calculate accurately in the first place.

Classical computers already do an impressive job, but some quantum systems are difficult to approximate without making simplifying assumptions. This is where quantum computing could eventually offer a genuine advantage, particularly for electronic structure calculations.

I'd approach the evidence in stages. First, demonstrate accurate calculations on relatively small molecules. Then increase molecular complexity, compare against trusted experimental measurements, and finally test whether the results improve decisions in real drug discovery projects.

It's a much less glamorous roadmap than promising miracle medicines, but it's probably how the real breakthrough will happen.

[Chris81]

I remain a little sceptical about quantum advantage in this particular field. Not because the underlying physics is questionable, but because classical chemistry software is improving incredibly quickly too.

Every time quantum researchers demonstrate a new capability, classical computing researchers find better algorithms, approximations, or hardware optimisations. The comparison needs to be against the best available classical methods, not an artificially weak benchmark.

A convincing result would show that a quantum-assisted approach solves a meaningful problem more accurately, more efficiently, or at a lower overall cost. Until then, I'm interested but not ready to declare the pharmaceutical industry transformed.